Get started
Author

Chris J. Schulze

OpenAlex ID: A5085646397
Abstract 3595: RMC-6291, a next-generation tri-complex KRASG12C(ON) inhibitor, outperforms KRASG12C(OFF) inhibitors in preclinical models of KRASG12C cancers
2022 · Robert J. Nichols, Y.C. Yang, et al. · Cancer Research · 38
Abstract 1943: SHP2 inhibition as the backbone of targeted therapy combinations for the treatment of cancers driven by oncogenic mutations in the RAS pathway
2020 · Jacqueline A. Smith, Mallika Singh, et al. · Cancer Research · 1
Abstract A103: Allosteric inhibition of SHP2 induces antitumor immunity in PD-1-sensitive tumors through modulation of both innate and adaptive mechanisms
2019 · Elsa Quintana, Kasia Mordec, et al. · Cancer Immunology Research · 1
Music Genre Classification
2014 · John Cast, Chris J. Schulze, et al. · 1
Abstract 5019: Allosteric inhibition of SHP2 suppresses CSF1R signaling and selectively reduces viability of M2 tumor associated macrophages contributing to anti-tumor immunity
2019 · Elsa Quintana, Chris J. Schulze, et al. · Cancer Research
Abstract 5019: Allosteric inhibition of SHP2 suppresses CSF1R signaling and selectively reduces viability of M2 tumor associated macrophages contributing to anti-tumor immunity
2019 · Elsa Quintana, Chris J. Schulze, et al. · Immunology
Works count: 6
Citation count: 41
H-index: 1
I10-index: 1
Year
Topic
Type